Matthan Nirupa R, Jalbert Susan M, Ausman Lynne M, Kuvin Jeffrey T, Karas Richard H, Lichtenstein Alice H
Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
Am J Clin Nutr. 2007 Apr;85(4):960-6. doi: 10.1093/ajcn/85.4.960.
The magnitude of the effect of soy protein on lipoprotein concentrations is variable. This discordance is likely attributable to the various forms of soy protein used and to unrecognized shifts in dietary fatty acid, cholesterol, and fiber.
The objective was to evaluate the effect of soybean processing as well as soy consumption relative to animal protein, independent of alterations in major dietary variables, on cardiovascular disease risk factors and vascular endothelial function.
Twenty-eight hypercholesterolemic subjects (LDL cholesterol >/=3.36 mmol/L) aged >50 y consumed each of 4 diets for 6-wk periods according to a randomized crossover design. The diets [55% of energy as carbohydrate, 30% of energy as fat, and 15% of energy as protein-7.5% of energy as experimental protein (37.5 g/d)] were designed to contain products made from either whole soybeans, soyflour, or soymilk and were compared with a diet containing an equivalent amount of animal protein (meat, chicken, and dairy products). The cholesterol, fiber, and fatty acid profiles of the diets were equalized. All food and drink were provided, and body weight was maintained throughout the study.
No significant differences in blood pressure, vascular endothelial function, or total cholesterol, VLDL-cholesterol, triacylglycerol, apolipoprotein B, or C-reactive protein concentrations were observed between the diets. Consumption of the soymilk diet resulted in a modest decrease (4%) in LDL-cholesterol concentrations compared with the animal-protein and soyflour diets (P < 0.05) and higher HDL-cholesterol (1%) and apolipoprotein A-I (2%) concentrations compared with the soybean and soyflour diets (P < 0.05).
The results suggest that the consumption of differently processed soy-based products and different types of protein (animal and soy) has little clinical effect on cardiovascular disease risk factors, including peripheral endothelial function, when other major dietary variables are held constant.
大豆蛋白对脂蛋白浓度的影响程度存在差异。这种不一致可能归因于所使用的大豆蛋白的各种形式以及饮食中脂肪酸、胆固醇和纤维未被识别的变化。
目的是评估大豆加工以及相对于动物蛋白的大豆摄入量,在不改变主要饮食变量的情况下,对心血管疾病危险因素和血管内皮功能的影响。
28名年龄大于50岁的高胆固醇血症受试者(低密度脂蛋白胆固醇≥3.36 mmol/L)按照随机交叉设计,每种饮食食用6周。这些饮食(碳水化合物提供55%的能量,脂肪提供30%的能量,蛋白质提供15%的能量——7.5%的能量作为实验性蛋白质(37.5克/天))被设计为包含由全大豆、大豆粉或豆浆制成的产品,并与含有等量动物蛋白(肉、鸡和乳制品)的饮食进行比较。饮食中的胆固醇、纤维和脂肪酸成分保持均衡。所有食物和饮料均提供,并且在整个研究过程中维持体重。
各饮食之间在血压、血管内皮功能或总胆固醇、极低密度脂蛋白胆固醇、三酰甘油、载脂蛋白B或C反应蛋白浓度方面未观察到显著差异。与动物蛋白和大豆粉饮食相比,食用豆浆饮食导致低密度脂蛋白胆固醇浓度适度降低(4%)(P<0.05),并且与大豆和大豆粉饮食相比,高密度脂蛋白胆固醇(1%)和载脂蛋白A-I(2%)浓度更高(P<0.05)。
结果表明,当其他主要饮食变量保持恒定时,食用不同加工的大豆基产品和不同类型的蛋白质(动物蛋白和大豆蛋白)对心血管疾病危险因素(包括外周内皮功能)几乎没有临床影响。